Group 1: strong increasing average (2 SD) |
1 |
133 |
Benzoate biosynthesis II (CoA-independent, non-β-oxidative) |
3 |
3.3E−03 |
Suberin biosynthesis |
3 |
6.9E−03 |
Phenylpropanoid biosynthesis, initial reactions |
2 |
1.2E−02 |
trans-Cinnamoyl-CoA biosynthesis |
2 |
1.2E−02 |
Adenine and adenosine salvage VI |
2 |
1.2E−02 |
2 |
74 |
S-Adenosyl-L-methionine cycle II |
4 |
1.4E−06 |
Jasmonic acid biosynthesis |
5 |
1.5E−06 |
Methionine degradation I (to homocysteine) |
3 |
3.1E−05 |
Traumatin and (Z)-3-hexen-1-yl acetate biosynthesis |
3 |
3.5E−05 |
Divinyl ether biosynthesis II |
3 |
3.5E−05 |
Linalool biosynthesis |
3 |
9.7E−05 |
S-Adenosyl-L-methionine biosynthesis |
2 |
7.3E−04 |
Ethylene biosynthesis from methionine |
3 |
9.8E−04 |
2′-Deoxymugineic acid phytosiderophore biosynthesis |
2 |
2.7E−03 |
UDP-D-xylose and UDP-D-glucuronate biosynthesis |
2 |
4.1E−03 |
Methylerythritol phosphate pathway |
2 |
4.1E−03 |
Tryptophan biosynthesis |
2 |
6.5E−03 |
Glycogen biosynthesis II (from UDP-D-glucose) |
2 |
7.8E−03 |
Methionine biosynthesis II |
2 |
1.0E−02 |
Colanic acid building blocks biosynthesis |
2 |
1.9E−02 |
Galactose degradation III |
2 |
1.9E−02 |
Group 2: moderately increasing average (approximately 1 SD) |
3 |
557 |
Homogalacturonan biosynthesis |
5 |
1.0E−02 |
Cellulose biosynthesis |
6 |
4.3E−02 |
Cytokinins-O-glucoside biosynthesis |
8 |
4.3E−02 |
4 |
493 |
Phenylpropanoid biosynthesis, initial reactions |
3 |
1.8E−02 |
trans-Cinnamoyl-CoA biosynthesis |
3 |
1.8E−02 |
5 |
357 |
Sucrose degradation I |
4 |
1.7E−02 |
Suberin biosynthesis |
4 |
1.7E−02 |
6 |
207 |
Jasmonic acid biosynthesis |
6 |
5.3E−05 |
Pyrimidine ribonucleosides degradation II |
3 |
5.7E−04 |
Methylerythritol phosphate pathway |
3 |
1.1E−02 |
β-Alanine biosynthesis II |
3 |
3.3E−02 |
Glutamine biosynthesis III |
3 |
3.3E−02 |
7 |
562 |
No results
|
|
|
8 |
408 |
Sucrose degradation III |
8 |
6.8E−04 |
Traumatin and (Z)-3-hexen-1-yl acetate biosynthesis |
3 |
1.7E−02 |
Alanine degradation II (to D-lactate) |
3 |
1.7E−02 |
Divinyl ether biosynthesis II |
3 |
1.7E−02 |
Sucrose degradation I |
4 |
1.7E−02 |
TCA cycle variation III (eukaryotic) |
5 |
1.7E−02 |
CDP-diacylglycerol biosynthesis II |
4 |
1.8E−02 |
CDP-diacylglycerol biosynthesis I |
4 |
1.8E−02 |
Triacylglycerol biosynthesis |
4 |
2.5E−02 |
Cyclopropane fatty acid biosynthesis |
3 |
2.9E−02 |
Cyclopropane and cyclopropene fatty acid biosynthesis |
3 |
2.9E−02 |
Glyoxylate cycle |
3 |
4.9E−02 |
Pyrimidine ribonucleotides interconversion |
3 |
5.0E−02 |
Group 3: moderately decreasing average (approximately 1 SD) |
9 |
456 |
No results
|
|
|
10 |
387 |
Stachyose biosynthesis |
3 |
3.1E−02 |
11 |
244 |
Photorespiration |
5 |
4.4E−04 |
12 |
399 |
Luteolin biosynthesis |
3 |
1.3E−02 |
Leucodelphinidin biosynthesis |
4 |
1.3E−02 |
Leucopelargonidin and leucocyanidin biosynthesis |
4 |
1.3E−02 |
Flavonol biosynthesis |
3 |
3.2E−02 |
Nitrogen fixation |
2 |
4.5E−02 |
13 |
500 |
No results
|
|
|
14 |
487 |
No results
|
|
|
Group 4: moderately decreasing averages that significantly deviate from the population average (high FPKM) |
15 |
150 |
Photosynthesis light reactions |
4 |
2.5E−05 |
Calvin–Benson–Bassham cycle |
5 |
1.3E−03 |
Gluconeogenesis I |
4 |
2.4E−02 |
Glycine cleavage complex |
2 |
4.7E−02 |
Glycolysis I |
4 |
4.7E−02 |
16 |
66 |
Methylerythritol phosphate pathway |
2 |
5.2E−03 |
Cyanate degradation |
2 |
5.2E−03 |
Photosynthesis light reactions |
2 |
5.2E−03 |
Calvin–Benson–Bassham cycle |
3 |
5.2E−03 |
Gluconeogenesis I |
3 |
7.2E−03 |
Rubisco shunt |
2 |
3.8E−02 |